158 related articles for article (PubMed ID: 29030133)
1. Use of a national database as a tool to identify primary medication non-adherence: The Estonian ePrescription system.
Laius O; Pisarev H; Volmer D; Kõks S; Märtson A; Maasalu K
Res Social Adm Pharm; 2018 Aug; 14(8):776-783. PubMed ID: 29030133
[TBL] [Abstract][Full Text] [Related]
2. Adherence to osteoporosis medicines in Estonia-a comprehensive 15-year retrospective prescriptions database study.
Laius O; Pisarev H; Maasalu K; Kõks S; Märtson A
Arch Osteoporos; 2017 Dec; 12(1):59. PubMed ID: 28643266
[TBL] [Abstract][Full Text] [Related]
3. Implementation of European Cross-border Electronic Prescription and Electronic Dispensing Service: Cross-sectional Survey.
Jõgi R; Timonen J; Saastamoinen L; Laius O; Volmer D
J Med Internet Res; 2023 Apr; 25():e42453. PubMed ID: 37014689
[TBL] [Abstract][Full Text] [Related]
4. Medication safety and the usability of electronic prescribing as perceived by physicians-A semistructured interview among primary health care physicians in Finland.
Kauppinen H; Ahonen R; Mäntyselkä P; Timonen J
J Eval Clin Pract; 2017 Dec; 23(6):1187-1194. PubMed ID: 28474487
[TBL] [Abstract][Full Text] [Related]
5. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population.
Adamson AS; Suarez EA; Gorman AR
JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045
[TBL] [Abstract][Full Text] [Related]
6. Using primary care prescribing data to improve GP awareness of antidepressant adherence issues.
Mabotuwana T; Warren J; Orr M; Kenealy T; Harrison J
Inform Prim Care; 2011; 19(1):7-15. PubMed ID: 22118331
[TBL] [Abstract][Full Text] [Related]
7. Primary medication non-adherence: analysis of 195,930 electronic prescriptions.
Fischer MA; Stedman MR; Lii J; Vogeli C; Shrank WH; Brookhart MA; Weissman JS
J Gen Intern Med; 2010 Apr; 25(4):284-90. PubMed ID: 20131023
[TBL] [Abstract][Full Text] [Related]
8. Trouble getting started: predictors of primary medication nonadherence.
Fischer MA; Choudhry NK; Brill G; Avorn J; Schneeweiss S; Hutchins D; Liberman JN; Brennan TA; Shrank WH
Am J Med; 2011 Nov; 124(11):1081.e9-22. PubMed ID: 22017787
[TBL] [Abstract][Full Text] [Related]
9. Effect of electronic prescribing with formulary decision support on medication tier, copayments, and adherence.
Pevnick JM; Li N; Asch SM; Jackevicius CA; Bell DS
BMC Med Inform Decis Mak; 2014 Aug; 14():79. PubMed ID: 25167807
[TBL] [Abstract][Full Text] [Related]
10. Validation of the electronic prescription as a method for measuring treatment adherence in hypertension.
Márquez-Contreras E; López García-Ramos L; Martell-Claros N; Gil-Guillen VF; Márquez-Rivero S; Pérez-López E; Garrido-Lopez MA; Farauste C; López-Pineda A; Casado-Martinez JJ; Orozco-Beltran D; Quesada JA; Carratalá-Munuera C
Patient Educ Couns; 2018 Sep; 101(9):1654-1660. PubMed ID: 29731180
[TBL] [Abstract][Full Text] [Related]
11. What can primary care prescribing data tell us about individual adherence to long-term medication?-comparison to pharmacy dispensing data.
Mabotuwana T; Warren J; Harrison J; Kenealy T
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):956-64. PubMed ID: 19609958
[TBL] [Abstract][Full Text] [Related]
12. Instantaneous detection of nonadherence: quality, strength, and weakness of an electronic prescription database.
Harbig P; Barat I; Lund Nielsen P; Damsgaard EM
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):323-8. PubMed ID: 22407597
[TBL] [Abstract][Full Text] [Related]
13. Pharmacy Customers' Experiences With Electronic Prescriptions: Cross-Sectional Survey on Nationwide Implementation in Finland.
Lämsä E; Timonen J; Ahonen R
J Med Internet Res; 2018 Feb; 20(2):e68. PubMed ID: 29475826
[TBL] [Abstract][Full Text] [Related]
14. Assessment of ePrescription quality: an observational study at three mail-order pharmacies.
Astrand B; Montelius E; Petersson G; Ekedahl A
BMC Med Inform Decis Mak; 2009 Jan; 9():8. PubMed ID: 19171038
[TBL] [Abstract][Full Text] [Related]
15. Primary medication nonadherence to oral oncology specialty medications.
Zuckerman AD; Shah NB; Perciavalle K; Looney B; Peter ME; DeClercq J; Moore R; Choi L; Reynolds VW
J Am Pharm Assoc (2003); 2022; 62(3):809-816.e1. PubMed ID: 35065885
[TBL] [Abstract][Full Text] [Related]
16. Primary medication nonadherence calculation method specifications impact resulting rates.
Zuckerman AD; DeClercq J; Shah NB; Reynolds VW; Peter ME; Pavlik AM; Choi L
Res Social Adm Pharm; 2022 Mar; 18(3):2478-2483. PubMed ID: 33926825
[TBL] [Abstract][Full Text] [Related]
17. Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data.
Burden AM; Paterson JM; Gruneir A; Cadarette SM
Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):67-74. PubMed ID: 25331490
[TBL] [Abstract][Full Text] [Related]
18. Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway.
Devold HM; Furu K; Skurtveit S; Tverdal A; Falch JA; Sogaard AJ
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):297-304. PubMed ID: 22237942
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of e-prescribing at a national level.
Parv L; Kruus P; Mõtte K; Ross P
Inform Health Soc Care; 2016; 41(1):78-95. PubMed ID: 25115948
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of the days' supply and the number of refills allowed recorded in Québec prescription claims databases for inhaled corticosteroids.
Blais L; Vilain A; Kettani FZ; Forget A; Lalonde G; Beauchesne MF; Ducharme FM; Lemière C
BMJ Open; 2014 Nov; 4(11):e005903. PubMed ID: 25432902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
